CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
38.410
1.13%
Market Trading Hours* (UTC) Open now
Closes on Friday at 15:30

Mon - Fri: 07:00 - 15:30

  • Summary
  • Historical Data
Trading сonditions
Spread 0.100
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.020032 %
Charges from full value of position ($-3.81)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.020032%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.00219 %
Charges from full value of position ($-0.42)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.00219%
Overnight fee time 21:00 (UTC)
Min traded quantity 0.001
Currency EUR
Margin 5.00%
Stock exchange Germany
Commission on trade 0%

Key Stats
Prev. Close 38.83
Open 38.585
1-Year Change 9.65%
Day's Range 38.34 - 38.585
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Oct 24, 2024 38.830 -0.305 -0.78% 39.135 39.230 38.825
Oct 23, 2024 39.055 0.045 0.12% 39.010 39.195 38.835
Oct 22, 2024 38.885 0.290 0.75% 38.595 38.950 38.485
Oct 21, 2024 38.695 -0.635 -1.61% 39.330 39.585 38.665
Oct 18, 2024 39.325 -0.070 -0.18% 39.395 39.660 39.265
Oct 17, 2024 39.490 -0.065 -0.16% 39.555 40.220 39.050
Oct 16, 2024 40.025 -0.405 -1.00% 40.430 40.505 39.840
Oct 15, 2024 40.725 1.005 2.53% 39.720 40.730 39.720
Oct 14, 2024 40.215 0.000 0.00% 40.215 40.325 40.000
Oct 11, 2024 40.100 0.585 1.48% 39.515 40.245 39.495
Oct 10, 2024 40.020 -0.295 -0.73% 40.315 40.715 39.810
Oct 9, 2024 40.160 0.530 1.34% 39.630 40.160 39.575
Oct 8, 2024 39.745 0.630 1.61% 39.115 39.830 38.930
Oct 7, 2024 39.315 -0.190 -0.48% 39.505 39.595 39.310
Oct 4, 2024 39.360 -0.120 -0.30% 39.480 39.685 39.155
Oct 3, 2024 39.610 -0.520 -1.30% 40.130 40.225 39.505
Oct 2, 2024 40.125 -0.405 -1.00% 40.530 40.570 40.005
Oct 1, 2024 40.555 -0.135 -0.33% 40.690 41.180 40.415
Sep 30, 2024 40.445 -0.160 -0.39% 40.605 40.880 40.300
Sep 27, 2024 40.990 0.435 1.07% 40.555 41.140 40.425

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Qiagen Company profile

About Qiagen NV

Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Qiagen NV revenues increased 20% to $2.25B. Net income increased 43% to $512.6M. Revenues reflect Consumables and Related Revenues segment increase of 23% to $1.99B, Instrumentation segment increase of 4% to $265.3M, United States segment increase of 25% to $909.7M, Europe & Middle East & Afric segment increase of 19% to $814.4M. Net income benefited from Restructuring decrease of 81% to $27.8M (expense).

Equity composition

1/2017, Shares Consolidation (Factor: 0.96296).

Industry: Biotechnology & Medical Research (NEC)

Hulsterweg 82
VENLO
LIMBURG 5912 PL
NL

News

US elections: Trump leads the polls, but tariff talk spooks investors

As the US elections get closer we look at how Trump’s tariff plans could affect markets.

15:02, 22 October 2024

Gold markets to trade

Last week, we explored the basic fundamental and technical approaches to gold trading. Having covered the key price drivers of this critical asset and how you might use data to trade it, you’re ready to assess the conditions for entry. But there are a range of markets that can effectively give you exposure to gold.

08:00, 21 October 2024

US earnings seasons off to a solid start as focus shifts to tech giants

The US earnings season has started on a positive note, with major banks exceeding expectations and boosting market sentiment.Key themes for the sector include investments in artificial intelligence, capital expenditure returns, and consumer trends in advertising and e-commerce. The S&P 500 continues to climb, driven by strong earnings, resilient economic growth, and the potential for interest rate cuts. Keep an eye on significant support and resistance levels as the market tests new record highs.

14:31, 17 October 2024

ECB Preview: cooling growth and inflation call for another rate cut

Markets are convinced the European Central Bank (ECB) will cut rates by 25 basis points again at Thursday’s meeting.

12:41, 16 October 2024

Australian labour force data forecast to reveal stable jobs market

Australia's labour market remained stable in September 2024, with the unemployment rate forecast to hold at 4.2%, supported by a 25,200 person rise in employment. Despite the economy teetering on the edge of recession, strong hiring trends persist, challenging market economists' predictions.

07:41, 15 October 2024

Applying fundamental and technical strategies to Gold Trading

Last week, we visualised the key potential drivers of gold in a chart focused on recent performance. Understanding the factors that can move gold prices is essential, but translating that knowledge into effective trading strategies is where the real potential can lie.

08:00, 14 October 2024

S&P 500 expected to deliver modest earnings growth in Q3

Earnings growth across the S&P 500 is expected to be modest in Q3, with a projected 4.2% increase in EPS, down from 7.8% in the previous quarter. Information technology, health care, and communication services are poised to drive growth, particularly IT with a forecasted 15% year-over-year EPS increase.

12:40, 11 October 2024

People also watch

Oil - Crude

70.66 Price
+0.500% 1D Chg, %
Long position overnight fee 0.0094%
Short position overnight fee -0.0314%
Overnight fee time 21:00 (UTC)
Spread 0.030

XRP/USD

0.53 Price
-1.240% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 0.01168

Gold

2,720.99 Price
-0.560% 1D Chg, %
Long position overnight fee -0.0176%
Short position overnight fee 0.0094%
Overnight fee time 21:00 (UTC)
Spread 0.30

US100

20,298.10 Price
+0.300% 1D Chg, %
Long position overnight fee -0.0248%
Short position overnight fee 0.0026%
Overnight fee time 21:00 (UTC)
Spread 1.8

Still looking for a broker you can trust?

Join the 650,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading